241 related articles for article (PubMed ID: 17880437)
1. Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review.
Kraut EH; Aledort LM; Arkin S; Stine KC; Wong WY
Haemophilia; 2007 Sep; 13(5):508-17. PubMed ID: 17880437
[TBL] [Abstract][Full Text] [Related]
2. Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high-responding inhibitors.
Smith OP
Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():22-5. PubMed ID: 12214142
[TBL] [Abstract][Full Text] [Related]
3. Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature.
Caviglia H; Candela M; Galatro G; Neme D; Moretti N; Bianco RP
Haemophilia; 2011 Nov; 17(6):910-9. PubMed ID: 21342367
[TBL] [Abstract][Full Text] [Related]
4. Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors.
Martinowitz U; Livnat T; Zivelin A; Kenet G
Haemophilia; 2009 Jul; 15(4):904-10. PubMed ID: 19473416
[TBL] [Abstract][Full Text] [Related]
5. Surgery in haemophilia patients with inhibitors, with special emphasis on orthopaedics: Madrid experience.
Rodriguez-Merchan EC; Jimenez-Yuste V; Gomez-Cardero P; Alvarez-Roman M; Martin-Salces M; Rodriguez de la Rua A
Haemophilia; 2010 May; 16(102):84-8. PubMed ID: 20536990
[TBL] [Abstract][Full Text] [Related]
6. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
Parameswaran R; Shapiro AD; Gill JC; Kessler CM;
Haemophilia; 2005 Mar; 11(2):100-6. PubMed ID: 15810910
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres.
Morfini M; Auerswald G; Kobelt RA; Rivolta GF; Rodriguez-Martorell J; Scaraggi FA; Altisent C; Blatny J; Borel-Derlon A; Rossi V
Haemophilia; 2007 Sep; 13(5):502-7. PubMed ID: 17880436
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey.
Zülfikar B; Aydogan G; Salcioglu Z; Oner AF; Kavakli K; Gursel T; Zülfikar H;
Haemophilia; 2012 May; 18(3):383-91. PubMed ID: 22103429
[TBL] [Abstract][Full Text] [Related]
9. Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela.
Boadas A; Fernández-Palazzi F; De Bosch NB; Cedeño M; Ruiz-Sáez A
Haemophilia; 2011 May; 17(3):422-7. PubMed ID: 21118333
[TBL] [Abstract][Full Text] [Related]
10. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series.
Valentino LA
Haemophilia; 2009 May; 15(3):733-42. PubMed ID: 19298380
[TBL] [Abstract][Full Text] [Related]
11. Ten-year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan.
Takedani H; Shima M; Horikoshi Y; Koyama T; Fukutake K; Kuwahara M; Ishiguro N
Haemophilia; 2015 May; 21(3):374-379. PubMed ID: 25521821
[TBL] [Abstract][Full Text] [Related]
12. Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors.
Berntorp E
Haemophilia; 2009 Jan; 15(1):3-10. PubMed ID: 19016901
[TBL] [Abstract][Full Text] [Related]
13. FEIBA in the treatment of acquired haemophilia A: results from the prospective multicentre French 'FEIBA dans l'hémophilie A acquise' (FEIBHAC) registry.
Borg JY; Négrier C; Durieu I; Dolimier E; Masquelier AM; Lévesque H;
Haemophilia; 2015 May; 21(3):330-337. PubMed ID: 25359571
[TBL] [Abstract][Full Text] [Related]
14. Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?
Rodriguez-Merchan EC; Hedner U; Heijnen L; Jimenez-Yuste V; Lee CA; Morfini M; Querol F; Roosendaal G; Santagostino E; Solimeno LP
Haemophilia; 2008 Nov; 14 Suppl 6():68-81. PubMed ID: 19134036
[TBL] [Abstract][Full Text] [Related]
15. Experience of four UK comprehensive care centres using FEIBA® for surgeries in patients with inhibitors.
Rangarajan S; Yee TT; Wilde J
Haemophilia; 2011 Jan; 17(1):28-34. PubMed ID: 20642787
[TBL] [Abstract][Full Text] [Related]
16. Cost minimization analysis to compare activated prothrombin complex concentrate (APCC) and recombinant factor VIIa for haemophilia patients with inhibitors undergoing major orthopaedic surgeries.
Bonnet PO; Yoon BS; Wong WY; Boswell K; Ewenstein BM
Haemophilia; 2009 Sep; 15(5):1083-9. PubMed ID: 19456876
[TBL] [Abstract][Full Text] [Related]
17. Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa.
Takedani H; Kawahara H; Kajiwara M
Haemophilia; 2010 Mar; 16(2):290-5. PubMed ID: 19925628
[TBL] [Abstract][Full Text] [Related]
18. Surgery in patients with haemophilia and high responding inhibitors: Izmir experience.
Balkan C; Karapinar D; Aydogdu S; Ozcan C; Ay Y; Akin M; Kavakli K
Haemophilia; 2010 Nov; 16(6):902-9. PubMed ID: 20518817
[TBL] [Abstract][Full Text] [Related]
19. Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision.
Dargaud Y; Lienhart A; Meunier S; Hequet O; Chavanne H; Chamouard V; Marin S; Negrier C
Haemophilia; 2005 Sep; 11(5):552-8. PubMed ID: 16128902
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis in haemophilia with inhibitors: update from international experience.
Carcao M; Lambert T
Haemophilia; 2010 Mar; 16 Suppl 2():16-23. PubMed ID: 20132334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]